Six Percent of CRCs Are Interval Tumors

Share this content:
Six Percent of CRCs Are Interval Tumors
Six Percent of CRCs Are Interval Tumors

(HealthDay News) — Six percent of patients with colorectal cancer (CRC) have interval cancers, which develop within six to 60 months of colonoscopy, according to a study published in the April issue of Gastroenterology.

N. Jewel Samadder, MD, from the University of Utah in Salt Lake City, and colleagues examined the proportion, characteristics, and factors that predict interval CRCs in a population-based study of Utah residents. Participants included 126,851 individuals who underwent colonoscopy examinations from 1995 through 2009. 

RELATED: Gastrointestinal Cancers Resource Center

Colonoscopy results were linked with cancer histories to identify patients who underwent colonoscopy 6 to 60 months before CRC diagnosis.

The researchers identified 2,659 diagnoses of CRC, of which 6% developed within 6 to 60 months of colonoscopy. There was no correlation between sex and age and interval CRCs. 

Compared with patients found to have CRC detected at colonoscopy or patients who did not develop cancer, a higher percentage of patients with interval CRC had adenomas at their index colonoscopy (57.2% vs 36% and 26%, respectively; P < 0.001). 

Compared with tumors detected at index colonoscopy, interval CRCs tended to be earlier stage and proximally located (odds ratio, 2.24; P < 0.001). 

Compared with patients found to have CRC at their index colonoscopy, patients with interval CRC were more likely to have family history of CRC (odds ratio, 2.27; P = 0.008) and had a lower risk of death (hazard ratio, 0.63; P < 0.001).

"These findings indicate that interval colorectal tumors may arise as the result of distinct biologic features and/or suboptimal management of polyps at colonoscopy," the researchers wrote.

Two authors disclosed financial ties to the biotechnology and medical device industries.

Reference

  1. Samadder NJ, Curtin K, Tuohy TMF, et al. Characteristics of Missed or Interval Colorectal Cancer and Patient Survival: A Population-Based Study. Gastroenterology. 2014; 146(4):950-960.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs